These benefits, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assistance the concept of concentrating on ACKR3 as a novel solution to modulate the opioid process, which could open new therapeutic avenues for opioid-linked disorders. Disclaimer: The above mentioned is https://abbiey056jfs0.smblogsites.com/profile